Hidetoshi Sakurai

Metalloprotease-dependent onset of blood circulation in zebrafish.

[Research for cell therapy by induced pluripotent stem cell].

In vitro modeling of paraxial mesodermal progenitors derived from induced pluripotent stem cells.

Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro.

Fetal skeletal muscle progenitors have regenerative capacity after intramuscular engraftment in dystrophin deficient mice.

In vitro characterization and engraftment of adipocytes derived from human induced pluripotent stem cells and embryonic stem cells.

Functional analysis of iPSC-derived myocytes from a patient with carnitine palmitoyltransferase II deficiency.

Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9.

Directed Myogenic Differentiation of Human Induced Pluripotent Stem Cells.

Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells.

MicroRNA-494 plays a role in fiber type-specific skeletal myogenesis in human induced pluripotent stem cells.

Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability.

Myogenic Differentiation from MYOGENIN-Mutated Human iPS Cells by CRISPR/Cas9.

A Skeletal Muscle Model of Infantile-onset Pompe Disease with Patient-specific iPS Cells.

A human iPS cell myogenic differentiation system permitting high-throughput drug screening.